Stem Cell Business News
Biweekly; 8-16 pages
for-profit, individual rates
Founded in 2002, Stem Cell Business News
provides in-depth news of public and private companies (U.S. and global) involved in stem
cell research. Includes basic and clinical research findings, legislation and regulation,
experimental therapies, finance and funding, patents,
strategic alliances, and much more.
Whether you're a competitor, supplier,
investor, analyst, etc. -- if your professional life requires reliable,
independent intelligence on stem cell research companies, you should
subscribe today to Stem Cell Business News!
Stem Cell Business News keeps you updated on stem
cell company news AND each issue takes a close look at public stem cell
company financial statements and other documents to find out what’s
really happening: beneath the surface … behind the headlines and the
The only independent biweekly report that covers
stem cell companies in depth -- including including public company SEC
10-K and 10-Q analysis, IPO plans, research and clinical trial news,
finance and funding, mergers and acquisitions, etc.
You'll make wiser, better informed investment
decisions by having at your fingertips detailed information on products
in development, preclinical and clinical trials, financial problems,
merger and acquisition activity, research and marketing collaborations,
significant risks, management changes, etc.
We do not forecast the market. We do not recommend buys, sells, or
holds. We simply read, interview, analyze, and report, so that potential
investors can make intelligent, and hopefully profitable, decisions
about their stem cell company portfolio. Available in PDF format only.
View a sample issue:
here. NOTE: To view this PDF file you will need Adobe Acrobat
Reader. To download and install this free view software, click on the
- For-profit rate: $345.00.
PDF via e-mail. This is the basic rate for public and private companies.
- Nonprofit rate:
PDF. Special rate for schools, hospitals, government agencies, nonprofit
- Individual rate:
$99.00. PDF. For
students, patients, and patients' families.
NOT for employees of any institution performing
stem cell research or doing business of any kind for or
with an organization performing stem cell research.
To choose one of these options,
click here. Your subscription order will be processed through
Google Checkout and will require a quick and simple activation of a
Google Checkout account.
Subscribe to both Stem Cell Research News AND
Stem Cell Business News at the same time at the corporate rate! Save $100 on both
Click here [link temporarily disabled]to order.